Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

G. Berthod · SciRah

Researcher profile · Semantic Scholar

G. Berthod

Share profile

G. Berthod — researcher profile on SciRah

h-index: 13
Works: 33
Citations: 686

Most-cited papers

Pulmonary sarcoid-like granulomatosis induced by ipilimumab.
G. Berthod, R. Lazor, I. Letovanec, E. Romano +5 more
2012Journal of Clinical Oncology180 citations
Semantic Scholar
Response to tumor-infiltrating lymphocyte adoptive therapy is associated with preexisting CD8+ T-myeloid cell networks in melanoma
D. Barras, E. Ghisoni, Johanna Chiffelle, A. Orcurto +41 more
2024Science immunology93 citations Open access
Semantic Scholar
Vaccination with LAG-3Ig (IMP321) and Peptides Induces Specific CD4 and CD8 T-Cell Responses in Metastatic Melanoma Patients—Report of a Phase I/IIa Clinical Trial
Amandine Legat, Hélène Maby-El Hajjami, P. Baumgaertner, Laurene Cagnon +14 more
2015Clinical Cancer Research86 citations Open access
Semantic Scholar
Treatment with the HIV protease inhibitor nelfinavir triggers the unfolded protein response and may overcome proteasome inhibitor resistance of multiple myeloma in combination with bortezomib: a phase I trial (SAKK 65/08)
C. Driessen, Marianne Kraus, M. Joerger, H. Rosing +13 more
2016Haematologica59 citations Open access
Semantic Scholar
Vaccination‐induced functional competence of circulating human tumor‐specific CD8 T‐cells
P. Baumgaertner, C. Jandus, J. Rivals, L. Derré +9 more
2012International Journal of Cancer53 citations Open access
Semantic Scholar
Bone mineral density in breast cancer patients treated with adjuvant letrozole, tamoxifen, or sequences of letrozole and tamoxifen in the BIG 1-98 study (SAKK 21/07).
K. Zaman, B. Thürlimann, J. Huober, A. Schönenberger +8 more
2012Annals of Oncology40 citations Open access
Semantic Scholar
The combination of stereotactic radiosurgery with immune checkpoint inhibition or targeted therapy in melanoma patients with brain metastases: a retrospective study
F. Martins, L. Schiappacasse, M. Levivier, C. Tuleasca +10 more
2019Journal of Neuro-Oncology31 citations Open access
Semantic Scholar
ALK-negative anaplastic large cell lymphoma with DUSP22 rearrangement has distinctive disease characteristics with better progression-free survival: a LYSA study
D. Sibon, B. Bisig, C. Bonnet, E. Poullot +19 more
2022Haematologica25 citations Open access
Semantic Scholar
Rituximab, bendamustine, and lenalidomide in patients with aggressive B cell lymphoma not eligible for high-dose chemotherapy or anthracycline-based therapy: phase I results of the SAKK 38/08 trial
F. Hitz, N. Fischer, T. Pabst, C. Caspar +6 more
2013Annals of Hematology23 citations Open access
Semantic Scholar
Multiple nivolumab-induced CNS demyelination with spontaneous resolution in an asymptomatic metastatic melanoma patient
V. Pillonel, V. Dunet, A. Hottinger, G. Berthod +4 more
2019Journal of Immunotherapy for Cancer22 citations Open access
Semantic Scholar
BRAF V600E mutation: A treatable driver mutation in pleomorphic xanthoastrocytoma (PXA)
S. Hofer, G. Berthod, C. Riklin, E. Rushing +1 more
2016Acta oncologica17 citations Open access
Semantic Scholar
Solitary choriocarcinoma in the lung.
G. Berthod, H. Bouzourène, C. Pachinger, S. Peters
2010Journal of Thoracic Oncology17 citations Open access
Semantic Scholar
Safety and Efficacy of Ipilimumab plus Nivolumab and Sequential Selective Internal Radiation Therapy in Hepatic and Extrahepatic Metastatic Uveal Melanoma
V. Aedo-Lopez, C. Gerard, S. Boughdad, Bianca Gautron Moura +7 more
2022Cancers16 citations Open access
Semantic Scholar
Sinonasal relapses of a primary isolated extranodal NK/T-cell lymphoma of the testis
B. Hallak, A. Cairoli, S. Bouayed, G. Berthod
2019BMJ Case Reports6 citations Open access
Semantic Scholar
Estimated Costs of the Ipilimumab–Nivolumab Therapy and Related Adverse Events in Metastatic Melanoma
B. Gautron Moura, C. Gerard, Nathalie Testart, M. Čaikovski +9 more
2022Cancers5 citations Open access
Semantic Scholar
Accuracy of sentinel lymph node dissection for melanoma staging in the presence of a collision tumour with a lymphoproliferative disease
D. Gero, Vanessa Queiros da Mota, A. Boubaker, G. Berthod +3 more
2014Melanoma research4 citations
Semantic Scholar
Tumor Microenvironment Cellular Crosstalk Predicts Response to Adoptive TIL Therapy in Melanoma
D. Barras, E. Ghisoni, Johanna Chiffelle, A. Orcurto +39 more
2022bioRxiv2 citations Open access
Semantic Scholar
[New melanoma immunotherapies: mechanisms of action, efficiency and management of toxicities].
B. Moura, K. Homicsko, G. Berthod, J. Cerottini +4 more
2015Revue medicale suisse2 citations
Semantic Scholar
[Melanoma: a new therapeutic era].
G. Berthod, K. Homicsko, H. Bouchaab, M. Matter +5 more
2011Revue medicale suisse2 citations
Semantic Scholar
Sorafenib plus selective internal radiotherapy with 90Y resin microspheres for the treatment of uveal melanoma with liver metastasis: a phase I trial
G. Berthod, C. Cisarovsky, Tatiana V Petrova, L. Decosterd +9 more
2025British Journal of Cancer1 citations Open access
Semantic Scholar
Adverse events and estimated costs with the combination of ipilimumab and nivolumab in metastatic melanoma patients.
B. Moura, C. Gerard, Nathalie Testart, Marian Caikovsky +9 more
20211 citations
Semantic Scholar
Unsorted single-cell RNA sequencing profiles of metastatic melanoma patients reveal the heterogeneity of melanoma-associated fibroblasts
K. Homicsko, D. Barras, V. A. Lopez, B. Moura +6 more
2019Annals of Oncology1 citations Open access
Semantic Scholar
[Diarrhea caused by systemic anti-cancer treatments].
Irma Dischl-antonioni, G. Berthod, P. Hiroz, S. Anchisi
2016Revue medicale suisse1 citations
Semantic Scholar
Abstract PD05-09: Prospective Assessment of CYP2D6 by Genotyping, Phenotyping and Measurement of Tamoxifen, 4-Hydroxy-Tamoxifen and Endoxifen in Breast Cancer Patients Treated with Tamoxifen
K. Zaman, E. Dahmane, C. Csajka, L. Perey +7 more
20101 citations
Semantic Scholar
[Hospital undernutrition: how not to ignore it any more?].
G. Berthod, J. Roduit, M. Roulet, P. C. Bertrand
2007Revue medicale suisse1 citations
Semantic Scholar
[Locally advanced and metastatic melanoma : novelties].
A. Huber, S. Latifyan, Asteria Nikolopoulou, K. Homicsko +3 more
2020Revue medicale suisse0 citations
Semantic Scholar
[Immunotherapy with immune checkpoint inhibitor and skin toxicity].
Pierre Simand, G. Berthod, L. Parmentier, S. Anchisi
2020Revue medicale suisse0 citations
Semantic Scholar
[Immunotherapy with immune checkpoint inhibitors and hepatitis].
Nathalie Baudoux, G. Berthod, F. Bally, P. Renard +1 more
2019Revue medicale suisse0 citations
Semantic Scholar
SAKK 65/08: A Phase I Dose Escalation Study of Bortezomib in Combination with Nelfinavir in Patients with Advanced Hematologic Malignancies
C. Driessen, Jürgen Bader, Marianne Kraus, M. Jörger +13 more
20140 citations
Semantic Scholar
Impact of tamoxifen dose on tamoxifen and its active metabolites exposure in breast cancer patients: preliminary results from a prospective, open-label trial
E. Dahmane, K. Zaman, M. Rindisbacher, G. Berthod +7 more
20120 citations
Semantic Scholar
Preferential enrichment of myeloid-derived suppressor cell subsets in patients with metastatic melanoma.
C. Meyer, Laurene Cagnon, N. Montandon, G. Berthod +4 more
20120 citations
Semantic Scholar
Prospective assessment of CYP2D6 by genotyping, phenotyping and measurement of tamoxifen, PD 05-09 4-hydroxy-tamoxifen and endoxifen in breast cancer patients treated with tamoxifen.
K. Zaman, E. Dahmane, L. Perey, T. Buclin +7 more
20100 citations
Semantic Scholar
Title: Vaccination with LAG-3Ig (IMP321) and Peptides Induces Specific CD4 and CD8 T-Cell Responses in Metastatic Melanoma Patients–Report
Amandine Legat, H. M. Hajjami, P. Baumgaertner, Laurene Cagnon +15 more
0 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

O. Michielin×15
Invite
O. Michielin — researcher profile on SciRah
K. Homicsko×9
Invite
K. Homicsko — researcher profile on SciRah
D. Speiser×6
Invite
D. Speiser — researcher profile on SciRah
M. Matter×5
Invite
M. Matter — researcher profile on SciRah

×5

Invite

M. Cuendet — researcher profile on SciRah

V. Aedo-Lopez×5

Invite

V. Aedo-Lopez — researcher profile on SciRah

Invite

E. Romano — researcher profile on SciRah

L. Kandalaft×4

Invite

L. Kandalaft — researcher profile on SciRah

Invite

K. Zaman — researcher profile on SciRah

Invite

C. Gerard — researcher profile on SciRah

Invite

S. Leyvraz — researcher profile on SciRah

Invite

S. Peters — researcher profile on SciRah